Expression of Smac/DIABLO in B-cell non-Hodgkin and Hodgkin lymphomas

Human Pathology

Volumn 37, Issue 11, 2006, Pages 1407-1413

  Ren, Yongsheng ^a   Akyurek, Nalan ^a   Schlette, Ellen ^a   Rassidakis, Georgios Z ^a   Medeiros, L Jeffrey ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

B cell non Hodgkin lymphoma; Hodgkin lymphoma; Immunohistochemistry; Smac DIABLO

Indexed keywords

SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ASSESSMENT; CONTROLLED STUDY; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTOMA; LYMPHOMA CELL; LYMPHOMA CELL LINE; MOLECULAR DYNAMICS; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; GENE EXPRESSION; HODGKIN DISEASE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOMA, B-CELL; MITOCHONDRIAL PROTEINS;

EID: 33750037357     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.06.006     Document Type: Article

References (23)

1. Kerr J.F.R., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 (1972) 239-257
2. Schattner E.J. Apoptosis in lymphocytic leukemias and lymphomas. Cancer Invest 20 (2002) 737-748
3. Jin Z., and El-Deiry W.S. Overview of cell death signaling pathways. Cancer Biol Ther 4 (2005) 139-163
4. Philchenkov A., Zavelevich M., Kroczak T.J., et al. Caspases and cancer: mechanisms of inactivation and new treatment modalities. Exp Oncol 26 (2004) 82-97
5. Crook N.E., Clem R.J., and Miller L.K. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol 67 (1993) 2168-2174
6. Tamm I., Kornblau S.M., Segall H., et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6 (2000) 1796-1803
7. Wrzesien-Kus A., Smolewski P., Sobczak-Pluta A., et al. The inhibitor of apoptosis protein family and its antagonists in acute leukemias. Apoptosis 9 (2004) 705-715
8. Hu S., Du M.Q., Park S.M., et al. cIAP2 is a ubiquitin protein ligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas. J Clin Invest 116 (2006) 174-181
9. de Graaf A.O., Van Krieken J.H., Tonnissen E., et al. Expression of C-IAP1, C-IAP2, and SURVIVIN discriminates different types of lymphoid malignancies. Br J Hematol 130 (2005) 852-859
10. Schlette E.J., Medeiros L.J., Goy A., Lai R., and Rassidakis G.Z. Survivin expression predicts poorer prognosis in anaplastic large cell lymphoma. J Clin Oncol 22 (2004) 1682-1688
11. Verhagen A.M., and Vaux D.L. Cell death regulation by the mammalian IAP antagonist Diablo/Smac. Apoptosis 7 (2002) 163-166
12. Du C., Fang M., Li Y., et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
13. Verhagen A.M., Ekert P.G., Pakusch M., et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102 (2000) 43-53
14. Hu S., and Yang X. Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J Biol Chem 278 (2003) 10055-10060
15. Jia L., Patwari Y., Kelsey S.M., et al. Role of Smac in human leukaemic cell apoptosis and proliferation. Oncogene 22 (2003) 1589-1599
16. Guo F., Nimmanapalli R., Paranawithana S., et al. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Blood 99 (2002) 3419-3426
17. Rassidakis G.Z., Thomaides A., Atwell C., et al. JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis. Mod Pathol 18 (2005) 1365-1370
18. Rassidakis G.Z., Thomaides A., Wang S., et al. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma. Leukemia 19 (2005) 1663-1669
19. Kitada S., Andersen J., Akar S., et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 91 (1998) 3379-3389
20. MacDonald I., Wang H., Grand R., et al. Transforming growth factor-beta 1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines. Blood 87 (1996) 1147-1154
21. Tanimoto T., Tsuda H., Imazeki N., et al. Nuclear expression of c-IAP-1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas. Cancer Lett 224 (2005) 141-151
22. Fulda S., Wick W., Weller M., et al. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8 (2002) 808-815
23. Yang L., Mashima T., Sato S., et al. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res 63 (2003) 831-837